115
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Factors for the Variability of Three Acceptable Maximal Expiratory Flow–Volume Curves in Chronic Obstructive Pulmonary Disease

ORCID Icon, , , , , ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 415-422 | Published online: 24 Feb 2021

References

  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; updated 2019. Available from: http://www.goldcopd.org/. Accessed Nov 30, 2018
  • Fukuchi Y, Nishimura M, Ichinose M, et al. COPD in Japan: the Nippon COPD Epidemiology study. Respirology. 2004;9:458–465. doi:10.1111/j.1440-1843.2004.00637.x
  • Miller J, Hankinson V, Brusasco, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–338. doi:10.1183/09031936.05.00034805
  • Japanese Respiratory Society. Guideline of respiratory function tests—spirometry, flow-volume curve, diffusing capacity of the lung (in Japanese). Tokyo: Japanese Respiratory Society, 2004. Japanese.
  • Gimeno F, van der Weele LT, Koeter GH, et al. Variability of forced oscillation (Siemens Siregnost FD 5) measurements of total respiratory resistance in patients and healthy subjects. Ann Allergy. 1993;71:56–60.
  • Stanescu D, Veriter C, Van Leemputten R, et al. Constancy of effort and variability of maximal expiratory flow rates. Chest. 1979;76:59–63. doi:10.1378/chest.76.1.59
  • Macdonald JB, Cole TJ, Seaton A, et al. Forced expiratory time–its reliability as a lung function test. Thorax. 1975;30:554–559. doi:10.1136/thx.30.5.554
  • Cochrane GM, Prieto F, Clark TJ. Intrasubject variability of maximal expiratory flow volume curve. Thorax. 1977;32:171–176. doi:10.1136/thx.32.2.171
  • Yoshimizu N. Factors influencing the variability of the forced expiratory curve and the flow volume curve in healthy male adults. J Yonago Med Ass. 1991;42:172–183.
  • McCarthy DS, Craig DB, Cherniack RM. Intraindividual variability in maximal expiratory flow-volume and closing volume in asymptomatic subjects. Am Rev Respir Dis. 1975;112:407–411. doi:10.1164/arrd.1975.112.3.407
  • Lebecque P, Desmond K, Swartebroeckx Y, et al. Measurement of respiratory system resistance by forced oscillation in normal children: a comparison with spirometric values. Pediatr Pulmonol. 1991;10:117–122. doi:10.1002/ppul.1950100214
  • Timonen KL, Randell JT, Salonen RO, et al. Short-term variations in oscillatory and spirometric lung function indices among school children. Eur Respir J. 1997;10:82–87. doi:10.1183/09031936.97.10010082
  • Mungall IP, Hainsworth R. Assessment of respiratory function in patients with chronic obstructive airways disease. Thorax. 1979;34:254–258. doi:10.1136/thx.34.2.254
  • Makita H, Nasuhara Y, Nagai K, et al. Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease. Thorax. 2007;11:932–937. doi:10.1136/thx.2006.072777
  • Nishimura M, Makita H, Nagai K, et al. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;185:44–52. doi:10.1164/rccm.201106-0992OC
  • American Thoracic Society. Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med. 1995;152:1107–1136. doi:10.1164/ajrccm.152.3.7663792
  • Ciba Guest Symposium Report. Terminology, definitions, and classification of chronic pulmonary emphysema and related condition. Thorax. 1959;14(4):286–299.
  • Braman SS. Chronic cough due to chronic bronchitis: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(104):S–115S.
  • Sasaki E, Nakamura M, Kida K, et al. Reference values for spirogram and blood gas analysis in Japanese non-smoking healthy adults. J Jpn Respir Soc. 2001;39:383–399.
  • Burrows JE, Kasik AH, Niden, et al. Clinical usefulness of the single breath pulmonary diffusing capacity test. Am Rev Resp Dis. 1961;84:789–806. doi:10.1164/arrd.1961.84.6.789
  • Nishimura M. Application of three-dimensional airway algorithms in a clinical study. Proc Am Thorac Soc. 2008;5:910–914. doi:10.1513/pats.200809-109QC
  • Paul W, Jones KM, Beeh KR, et al. Minimal clinically important differences in pharmacological trials. Am J Respir Crit Care Med. 2014;189:250–255. doi:10.1164/rccm.201310-1863PP